DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice

Vaccine

Volumn 21, Issue 11-12, 2003, Pages 1089-1093

  Donati, Manuela ^a   Sambri, Vittorio ^a   Comanducci, Maurizio ^b   Di Leo, Korinne ^a   Storni, Elisa ^a   Giacani, Lorenzo ^a   Ratti, Giulio ^b   Cevenini, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CHIRON VACCINES   (Italy)

Author keywords

Chlamydia trachomatis; Mouse genital infection; pgp3 DNA immunization

Indexed keywords

BACTERIAL VACCINE; PLASMID DNA; PROTEIN PGP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENITAL SYSTEM; IMMUNIZATION; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; TISSUE HOMOGENATE; UTERINE TUBE; VAGINA;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE PROGRESSION; FEMALE; GENETIC VECTORS; IMMUNIZATION; IMMUNOTHERAPY, ACTIVE; MICE; MICE, INBRED C3H; PELVIC INFLAMMATORY DISEASE; SALPINGITIS; VACCINES, DNA; VAGINOSIS, BACTERIAL;

EID: 0037424158     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00631-X     Document Type: Article

References (28)

1. Cates W., Rolf R.T., Aral S.O. Sexually transmitted diseases, pelvic inflammatory disease and infertility: an epidemiologic update. Epidemiol. Rev. 12:1990;199-220.
2. Pal S., Theodor I., Peterson E.M., de la Maza M.L. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect. Immun. 65(8):1997;3361-3369.
3. Theodor I., Peterson P.S., de la Maza L.M. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge. Infect. Immun. 69(10):2001;6240-6247.
4. Morrison R.P., Caldwell H.D. Immunity to murine chlamydial genital infection. Infect. Immun. 70(6):2002;2741-2751.
5. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Ann. Rev. Immunol. 15:1997;617-648.
6. Lowrie D.B., Tascon R.E., Colston M.J., Silva C.L. Towards a DNA vaccine against tuberculosis. Vaccine. 12(16):1994;1537-1540.
7. Xu D., Liew F.Y. Genetic vaccination against leishmaniasis. Vaccine. 12(16):1994;1534-1536.
8. Zhang D.J., Yang X., Berry J., Shen C., McClarty G., Brunham R.C. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J. Infect. Dis. 176:1997;1035-1040.
9. Pal S., Barnhart K.M., Wei Q., Abai A.M., Peterson E.M., de la Maza L.M. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine. 17(5):1999;459-465.
10. Comanducci M.R., Manetti L., Bini A.et al. Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection. Infect. Immun. 62(12):1994;5491-5497.
11. Farencena A., Comanducci M., Donati M., Ratti G., Cevenini R. Characterization of a new isolate of Chlamydia trachomatis which lacks the common plasmid and has properties of biovar trachoma. Infect. Immun. 65(7):1997;2965-2969.
12. Comanducci M., Ricci S., Cevenini R., Ratti G. Diversity of the chlamydial common plasmid in biovars with different pathogenicity. Plasmid. 23(2):1990;149-154.
13. Bas S., Muzzin P., Ninet B., Bornand J.E., Scieux C., Vischer T.L. Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens. J. Clin. Microbiol. 39(4):2001;1368-1377.
14. Bas S., Muzzin P., Vischer T.L. Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens. J. Clin. Microbiol. 39(11):2001;4082-4085.
15. Bas S., Genevay S., Schenkel M.C., Vischer T.L. Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford). 41(9):2002;1017-1020.
16. Barnett S.W., Rajasekar S., Legg H.et al. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine. 15(8):1997;869-873.
17. Darville T., Andrews C.W., Laffoon K.K., Shymasani W., Kishen L.R., Rank R.G. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 65(8):1997;3065-3073.
18. Su H., Feilzer K., Caldwell H.D., Morrison R.P. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65(6):1997;1993-1999.
19. Morrison R.P., Feilzer K., Tumas D.B. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63(12):1995;4661-4668.
20. Rank R.G., Soderberg L.S.F., Barron A.L. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect. Immun. 48(3):1985;847-849.
21. Tuffrey M., Falder P., Gale J., Taylor-Robinson D. Infertility in mice infected genitally with a human strain of Chlamydia trachomatis. J. Rep. Fertil. 78(1):1986;251-260.
22. Tuffrey M., Falder P., Gale J., Taylor-Robinson D. Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br. J. Exp. Pathol. 67(4):1986;605-616.
23. Grayston J.T., Wang S.P. New knowledge of Chlamydiae and the diseases they cause. J. Infect. Dis. 132(1):1975;87-105.
24. Washington A.E., Aral S.O., Wolner-Hanssen P., Grimes D.A., Holmes K.K. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA. 266:1991;2581-2586.
25. Comanducci M., Cevenini R., Moroni A.et al. Expression of a plasmid gene of Chlamydia trachomatis encoding a novel 28 kDa antigen. J. Gen. Microbiol. 139:1993;1083-1092.
26. Bini L., Sanchez-Campillo M., Santucci A.et al. Mapping of Chlamydia trachomatis proteins by immobiline-polyacrylamide two-dimensional electrophoresis: spot identification by N-terminal sequencing and immunoblotting. Electrophoresis. 17(1):1996;185-190.
27. Kojima Y., Xin K.Q., Ooki T.et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine. 20(23-24):2002;2857-2865.
28. Singh M., Briones M., Ott G., O'Hagan D. Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. U.S.A. 97(2):2000;811-816.